Institut de recherche biomédicale
     
    Vous êtes ici : Accueil / La Recherche / Infection, Immunité, Inflammation / Equipe V. Witko-Sarsat

    Publications de l'équipe : Neutrophiles et vascularites

    110 publication(s) trouvée(s)

    • Witko-Sarsat, V., Thieblemont, N. Granulomatosis with polyangiitis (Wegener granulomatosis): A proteinase-3 driven disease? Joint Bone Spine 2018; 85(2):185-189
    • Tacnet-Delorme, P., Gabillet, J., Chatfield, S., Thieblemont, N., Frachet, P., Witko-Sarsat, V. Proteinase 3 Interferes With C1q-Mediated Clearance of Apoptotic Cells Front Immunol 2018; 9:818
    • Hadjadj, J., Canaud, G., Mirault, T., Samson, M., Bruneval, P., Regent, A., Goulvestre, C., Witko-Sarsat, V., Costedoat-Chalumeau, N., Guillevin, L., Mouthon, L., Terrier, B., French Vasculitis Study, Group mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G Rheumatology (Oxford) 2018; 57(6):1011-1020
    • Terrier, B., Pagnoux, C., Perrodeau, E., Karras, A., Khouatra, C., Aumaitre, O., Cohen, P., Decaux, O., Desmurs-Clavel, H., Maurier, F., Gobert, P., Quemeneur, T., Blanchard-Delaunay, C., Bonnotte, B., Carron, P. L., Daugas, E., Ducret, M., Godmer, P., Hamidou, M., Lidove, O., Limal, N., Puechal, X., Mouthon, L., Ravaud, P., Guillevin, L., French Vasculitis Study, Group Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides Ann Rheum Dis 2018; 77(8):1150-1156
    • Alkan, M., Sayes, F., Ramadan, A., Machavoine, F., Dy, M., Schneider, E., Thieblemont , N. Basophil activation through TLR2 and TLR4 signaling pathways AIMS Allergy and Immunology 2018; 2(3):126-40
    • Berthelot, J. M., Puechal, X. Impaired intracellular pathogen clearance and inflammatory joint disease: Is Whipple's disease a guiding light? Joint Bone Spine 2018; 85(5):531-536
    • Thieblemont, N., Witko-Sarsat, V., Ariel, A. Regulation of macrophage activation by proteins expressed on apoptotic neutrophils: Subversion towards autoimmunity by proteinase 3 Eur J Clin Invest 2018; 48 Suppl 2:e12990
    • Mouasni, S., Tourneur, L. FADD at the Crossroads between Cancer and Inflammation Trends Immunol 2018; 39(12):1036-1053
    • Chatfield, S. M., Thieblemont, N., Witko-Sarsat, V. Expanding Neutrophil Horizons: New Concepts in Inflammation J Innate Immun 2018; 10(5-6):422-431
    • Tiffreau, V., Rannou, F., Kopciuch, F., Hachulla, E., Mouthon, L., Thoumie, P., Sibilia, J., Drumez, E., Thevenon, A. Postrehabilitation Functional Improvements in Patients With Inflammatory Myopathies: The Results of a Randomized Controlled Trial Arch Phys Med Rehabil 2017; 98(2):227-234
    • Legendre, P., Regent, A., Thiebault, M., Mouthon, L. Anti-endothelial cell antibodies in vasculitis: A systematic review Autoimmun Rev 2017; 16(2):146-153
    • Chaigne, B., Mouthon, L. Mechanisms of action of intravenous immunoglobulin Transfus Apher Sci 2017; 56(1):45-49
    • Regent, A., Ly, K. H., Groh, M., Khifer, C., Lofek, S., Clary, G., Chafey, P., Baud, V., Broussard, C., Federici, C., Labrousse, F., Mesturoux, L., Le Jeunne, C., Vidal, E., Brezin, A., Witko-Sarsat, V., Guillevin, L., Mouthon, L. Molecular analysis of vascular smooth muscle cells from patients with giant cell arteritis: Targeting endothelin-1 receptor to control proliferation Autoimmun Rev 2017; 16(4):398-406
    • Dumoitier, N., Chaigne, B., Regent, A., Lofek, S., Mhibik, M., Dorfmuller, P., Terrier, B., London, J., Berezne, A., Tamas, N., Varin-Blank, N., Mouthon, L. Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor beta and Activate Fibroblasts Arthritis Rheumatol 2017; 69(5):1078-1089
    • Puechal, X. Which breakthroughs in the management of systemic vasculitides? [Quelles avancées dans la prise en charge des vascularites systémiques ?] Revue du Rhumatisme Monographies 2017; 84(3):205-206
    • Witko-Sarsat, V., Thieblemont, N. Granulomatosis with polyangiitis (Wegener): A proteinase 3-driven disease? [Granulomatose avec polyangéite (Wegener) : maladie de la protéinase-3 ?] Revue du Rhumatisme Monographies 2017; 84(3):236-240
    • Chaigne, B., Watier, H. Theranostic of biopharmaceuticals Pharmacol Ther 2017; 175:67-74
    • Marteyn, B. S., Burgel, P. R., Meijer, L., Witko-Sarsat, V. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis Front Cell Infect Microbiol 2017; 7:243
    • Andre, R., Cottin, V., Saraux, J. L., Blaison, G., Bienvenu, B., Cathebras, P., Dhote, R., Foucher, A., Gil, H., Lapoirie, J., Launay, D., Loustau, V., Maurier, F., Pertuiset, E., Zenone, T., Seebach, J., Costedoat-Chalumeau, N., Puechal, X., Mouthon, L., Guillevin, L., Terrier, B., French Vasculitis Study, Group Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature Autoimmun Rev 2017; 16(9):963-969
    • Martin, K. R., Witko-Sarsat, V. Proteinase 3: the odd one out that became an autoantigen J Leukoc Biol 2017; 102(3):689-698
    Equipes du département